REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 26 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,541,000 | -14.7% | 1,462,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1,806,000 | -27.6% | 1,462,000 | -45.0% | 0.00% | 0.0% |
| Q4 2022 | $2,494,000 | -10.3% | 2,660,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,780,000 | +1.2% | 2,660,000 | -15.5% | 0.00% | 0.0% |
| Q2 2022 | $2,747,000 | -11.9% | 3,148,000 | -5.5% | 0.00% | 0.0% |
| Q1 2022 | $3,118,000 | -12.0% | 3,332,000 | -17.7% | 0.00% | 0.0% |
| Q4 2021 | $3,544,000 | -37.5% | 4,047,000 | -17.9% | 0.00% | 0.0% |
| Q3 2021 | $5,669,000 | -1.5% | 4,932,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $5,754,000 | +5.2% | 4,932,000 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $5,471,000 | – | 4,882,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| READYSTATE ASSET MANAGEMENT LP | 17,500,000 | $21,551,250 | 2.00% |
| CSS LLC/IL | 17,325,000 | $21,353,288 | 1.41% |
| SSI INVESTMENT MANAGEMENT LLC | 7,938,000 | $9,735,966 | 0.68% |
| Boussard & Gavaudan Investment Management LLP | 5,000 | $6,146,212 | 0.58% |
| Context Capital Management, LLC | 3,249 | $4,001 | 0.34% |
| LINDEN ADVISORS LP | 20,000,000 | $24,645,586 | 0.26% |
| AVIVA PLC | 22,325,000 | $27,381,613 | 0.12% |
| DeepCurrents Investment Group LLC | 2,384,000 | $2,931,980 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 35,500,000 | $43,718 | 0.06% |
| D. E. Shaw & Co., Inc. | 34,364,000 | $42,380,365 | 0.04% |